Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ: TNDM )

35.15 -2.38 (-6.34%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TNDM
WHY: NEW YORK, NY - (NewMediaWire) - September 19, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August... 
Via TheNewswire.com
Topics Economy Lawsuit
Exposures Financial Interest Rates Legal
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TNDM
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy Lawsuit
Exposures Financial Interest Rates Legal
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Tandem Diabetes Care, Inc. (TNDM) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Tandem Diabetes Care, Inc. Securities Fraud Class Action
From Robbins LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
TNDM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors
From Law Offices of Howard G. Smith
Via Business Wire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM
WHY: NEW YORK, NY - (NewMediaWire) - September 17, 2023 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of... 
Via TheNewswire.com
Topics Economy Lawsuit
Exposures Financial Interest Rates Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UiPath, Tandem, and Leslie’s and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy Lawsuit
Exposures Financial Interest Rates Legal
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – TNDM
From The Rosen Law Firm, P.A.
Via Business Wire
TANDEM DIABETES CARE, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
From Bernstein Liebhard LLP
Via GlobeNewswire
TANDEM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
TNDM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead the Tandem Diabetes Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Tandem Diabetes Care, Inc.
From Robbins LLP
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi System
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Present at the UBS MedTech, Tools and Genomics Summit 2023
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Mobi, World’s Smallest Durable Insulin Delivery System, Receives FDA Clearance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Second Quarter 2023 Financial Results on August 3, 2023
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Present at the Jefferies Healthcare Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology
From Tandem Diabetes Care, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.